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Abstract.  We have used a transfection based approach 
to analyze the role of neural cell adhesion molecule 
(NCAM) in myogenesis at the stage of myoblast fusion 
to form multinucleate myotubes. Stable cell lines of 
myogenic C2 cells were isolated that express the trans- 
membrane  140- or 180-kD NCAM isoforms or the 
glycosylphosphatidylinositol (GPI) linked isoforms of 
120 or 125 kD.  We found that expression of the 
140-kD transmembrane  isoform led to a potent en- 
hancement of myoblast fusion.  The  125-kD GPI-linked 
NCAM also enhanced the rate of fusion but less so 
when a direct comparison of cell surface levels of the 
140-kD transmembrane  form was carried out. While 
the 180-kD transmembrane  NCAM isoform was effec- 
tive in promoting C2 cell fusion similar to the  140-kD 
isoform, the  120-kD isoform did not have an effect on 
fusion parameters.  It is possible that these alterations 
in cell fusion are associated with cis NCAM interac- 
tions in the plane of the membrane.  While all of the 
transfected human NCAMs (the transmembrane  140- 
and  180-kD isoforms and the  125- and  120-kD GPI 
isoforms) could be clustered in the plane of the 
plasma membrane by species-specific antibodies there 
was a concomitant clustering of the endogenous mouse 
NCAM protein in all cases except with the 120-kD 
human isoforrn.  These studies show that different iso- 
forms of NCAM can undergo specific interactions in 
the plasma membrane which are likely to be impor- 
tant in fusion.  While the transmembrane and the 125- 
kD GPI-anchored NCAMs are capable of enhancing 
fusion the  120-kD GPI NCAM is not.  Thus it is likely 
that interactions associated with NCAM intracellular 
domains and also the muscle specific domain (MSD) 
region in the extracellular domain of the GPI-linked 
125-kD NCAM are important.  In particular this is the 
first role ascribed to the O-linked carbohydrate con- 
taining MSD region which is specifically expressed in 
skeletal muscle. 
T 
HE fusion of mononucleate myoblast cells to  form 
multinucleate  myotubes is a central  event in skeletal 
development and leads ultimately  to the formation  of 
mature muscle fibers. The myoblast to myotube transition  is 
also characterized  by the expression  of a large number of 
structural proteins required for the correct functioning of the 
myofibrillar  apparatus  and other components required for 
different aspects of terminal  differentiation.  The process of 
skeletal muscle fusion has been studied extensively but the 
exact mechanism is not known (Knudsen,  1990; Wakelam, 
1985, 1988). Fusion is clearly complex and multi-stage  and 
involves the operation of  both cell-cell and cell-extracellular 
matrix  interactions  (Knudsen,  1990;  Mege et  al.,  1992; 
Dickson et al., 1990). A large number of studies have shown 
that  in vitro,  myoblasts  express  both a calcium-dependent 
and -independent  cell adhesion  system,  and that  both are 
likely required for fusion to proceed (Pizzey et al.,  1988; 
Gibralter and Turner, 1985; Knudsen, 1985). There are also 
additional  complexities  in vivo. For instance,  in vivo myo- 
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genesis proceeds in two phases called primary and second- 
ary and may involve the use of specific populations  of myo- 
blasts (Miller 1991; Stockdale,  1992). After the formation 
of primary myofibers from the fusion of primary myoblasts 
the secondary myoblasts attach to the primary myofibers but 
do not fuse with them. Instead they fuse with other second- 
ary myoblasts. 
The molecular basis of cell-cell interactions  in skeletal 
muscle myoblasts is starting  to be understood and a number 
of  gene  products  active  in  the  process  identified.  The 
calcium-dependent  adhesion  system  in  myoblasts  is  as- 
sociated with the expression  and operation of a set of cell 
adhesion  molecules  (CAMs)~ called  cadherins  (Takeichi, 
1988, 1991). In skeletal  muscle,  three cadherins  have been 
identified namely N-cadherin  (Knudsen et al.,  1990; Mege 
et al.,  1992; Walsh et al.,  1990), M-cadherin  (Donalies  et 
al., 1991; Moore and Walsh, 1993) and T-cadherin (Ranscht, 
1. Abbreviations used in thispaper: BrdU, bromodeoxyuridine; CAM, cell 
adhesion molecule; GPI, glycosylphosphatidylinositol;  HS, horse serum; 
MSD, muscle-specific domain; PIPLC, phosphatidylinositol-specific  phos- 
pholipase C. 
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relative importance of these three cadherins is not clear al- 
though synthetic peptides that block N-cadherin-mediated 
adhesion have dramatic effects on blocking fusion (Mege et 
al., 1992). Two calcium-independent adhesion systems have 
been  identified in  muscle.  The  Ig  superfamily member 
VCAM-1 has been identified on myoblasts and myotubes and 
its partner,  the/32  integrin VLA4 on myotubes (Rosen et 
al., 1992). A scheme has been presented where the specific 
interaction of this heterophilic CAM pair may account for 
the specificity of primary and secondary myoblast fusion 
(Rosen et al.,  1992).  Antibodies reactive with the/31  inte- 
grins have major inhibitory effects  on myoblast fusion in 
vitro (Menko and Boettiger,  1980) although it is not clear 
whether these were due to blockade of  the interaction of inte- 
grins with VCAM-1 or with the extracellular matrix binding 
sites. The neural cell adhesion molecule (NCAM) is the sec- 
ond Ig superfamily member present on the cell surface of 
myoblasts (Moore and Waish, 1985; Sanes et al., 1986). The 
pattern of expression of NCAM is tightly regulated during 
development of skeletal muscle (Lyons et al.,  1992).  In 
proliferating myoblasts the predominant NCAM isoform is 
a 140-kD transmembrane species whereas myotubes express 
a  125-kD  glycosylphosphatidylinositol (GPI)  linked form 
(Covault et al,, 1986; Moore et ai., 1987). There are several 
consequences of this isoform switch. First, there is a change 
in membrane anchorage of NCAM and second, due to alter- 
native splicing there is the expression of  an extracellular mus- 
cle  specific  domain  (MSD-1)  which  bears  an  O-linked 
oligosaccharide (Dickson  et al.,  1987;  Hamshere et  al., 
1992; Pan et al., 1992; Thompson et al., 1989; Walsh et al., 
1989).  During  myogenesis  there  is  an  upregulation  of 
NCAM  expression by  '~4-5-fold which is  due to an in- 
creased transcriptional rate (Roubin and Goridis, 1992).  A 
number of pieces of data support a role for NCAM in fusion 
(Dickson et al.,  1990;  Knudsen et al.,  1990).  Calcium- 
independent adhesion which is a prerequisite for fusion has 
been shown to be sufficient to allow aggregation in mouse 
myoblasts and that antibodies to NCAM inhibited this adhe- 
sion  (Knudsen et  al.,  1990).  Also,  phosphatidylinositol- 
specific phospholipase C (PIPLC) which removes the 125- 
kD GPI-linked NCAM inhibits myoblast aggregation (Knud- 
sen et al., 1989) while overexpression of 125-kD NCAM by 
gene transfer enhances fusion (Dickson et al.,  1990). 
To analyze the role of NCAM further, we have used a 
transfection-based approach which has been used previously 
to define the role of NCAM in recognition events (Dickson 
et al., 1990; Doherty et al., 1989; Pizzey et ai., 1989). We 
have shown that the C2 myoblast cell line when transfected 
with a  125-kD GPI-linked NCAM containing the MSD re- 
gion showed an enhanced rate of myoblast fusion which was 
due to the introduced transgene (Dickson et al.,  1990).  In 
the present study we have extended our analyses to assess the 
role of membrane association and also alternative splicing in 
the extracellular domain of NCAM on muscle fusion. We 
show that the  140-kD  transmembrane isoform of NCAM 
causes a dramatic increase in muscle fusion while the GPI- 
linked 120-kD  isoform which is lacking the MSD-1  region 
has no effect on C2 fusion. Thus the NCAM component of 
myoblast fusion can be modulated by the expression of its in- 
tracellular domain and also the MSD-1  region in the ex- 
tracellular domain. 
Materials and Methods 
Cell Culture and Transfection 
The C2 mouse skeletal muscle cell line was grown on  150~mm culture 
dishes in DME containing 2 mM L-glutamine and supplemented with 10% 
FCS. Cells were maintained at 37°C in 8 % CO2 and used between pas- 
sages 22 and 26, always at subconfluent density. To induce fusion, myoblasts 
were reseeded at 3.2  ×  104 cells per cm  2 on collagen (Vitrogen) (Collagen 
Corp., Palo Alto, CA) coated culture dishes, allowed to adhere overnight 
and then the media changed to DME containing 5% horse serum (HS). 
Populations of C2 cells were transfected singly with eukaryotic expres- 
sion vectors encoding four different NCAM isoforms. These were trans- 
membrane NCAM of 180 kD (Doherty et al., 1992a)  or 140 kD (Doberty 
et al., 1990) and GPI-anchured forms of 125 kD (Dickson et al., 1990; 130- 
berry et al., 1990) or 120 kD (Doherty et al., 1990).  For the 120, 125, and 
140 kD expressing eDNA NCAM clones the expression vector used was 
pH~Apr-l-neo which contains the ~-actin promoter while for the 180-kD 
construct, pcDNAl-neo which contains the cytomegalovirus promoter was 
used. C2 cells (1  ×  104) in a 60-ram dish were transfected with 3 #g of 
the expression plasmid using the calcium phosphate protocol provided with 
the Cell Phect Transfection Kit (Pharmacia Fine Chemicals, Piscataway, 
NJ). After 16 h, cells were transferred to 150-ram dishes containing DME, 
10% FCS, 2 mM glutamine, and 0.5 mg/ml G418.  After 10 d of culture, 
G418 resistant colonies were isolated and analyzed for human NCAM ex- 
pression. 
Characterization of Transfected C2 Cells 
Control and transfected C2 cells were characterized for the expression of 
human NCAM by immunocytochemistry  and Western blotting using the hu- 
man NCAM-specific mAb Ericq (Bourne et al.,  1991). 
For immunocytochemistry cells were incubated sequentially with the 
Eric-1 mAb (l:lO0 dilution of ascites fluid), biotinylated anti-mouse Ig and 
Texas  red streptavidin (Amersham International,  Amersham,  UK) both 
diluted 1:500.  Western blotting of C2 cell extracts was carried out as de- 
scribed previously (Dickson et al., 1990) using the Ericq mAb at a  hi00 
dilution and the ECL Western blotting reagents from Amersham Interna- 
tional (Doherty et al.,  1991). 
The relative level of human NCAM on individual clones was determined 
using radioimmunoassay by measuring the binding of a saturating  concen- 
tration of a 12SI-Fab fragment of Eric-1 mAb. Saturating levels of 125I Eric 
Fab (22.4/zCi/~g) were incubated for 60 rain with a range of cell numbers 
(4-10  ×  103) in microtiter plates. Cells were then washed three times with 
PBS and the bound t2SI-Fab extracted with 0.1 M  NaOH.  Samples were 
counted in a Beckman 6000 scintillation counter (Beckman Instruments, 
Inc., Fullerton, CA). 
Analysis of  Myoblast Fusion 
C2 cells were plated at a density of 3.2 ×  104/cm  2 on either 24-ram culture 
dishes or  individual  wells  of Lab-Tek  eight-chamber  slides  (Lab-Tek, 
Naperville, IL) coated with collagen. After 1-4 d of culture, samples were 
analyzed for biochemical differentiation by measuring creatine kinase lev- 
els. This was carried out using the UV-CK-NACS kit (Boehringer Mann- 
helm,  Lewes, UK). Protein was measured using the Bio Rad Bradford 
reagent (Bio Paid Laboratories, Richmond, CA). Morphological differen- 
tiation was assessed  by measuring the total number of  nuclei in wells of Lab- 
Tek slides and also the number of myotube associated nuclei. Nuclei were 
identified by staining with the Hoescht 33258 dye after permeabilization of 
cells with 100% methanol for 8 rain at -20°C. Samples were viewed under 
UV light on a Zeiss Axiophot microscope (Zeiss, Carl Ltd., Herts, UK) 
and generally the cells in three separate fields measured. 
Blockade of  Fusion with Antibodies to NCAM 
The ERICA  mAb has been shown previously to block human NCAM- 
mediated interactions in C2 cells transfected with human NCAM cDNAs 
(Dickson et al.,  1990).  Either a monovalent Fab fragment of the ERICA 
mAb or control non specific mouse Ig was added at a concentration of 300 
pg/ml to culture 24 h after plating. The fusion media was changed every 
24 h according to the time course of the assay. 
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Subconfluent cultures of replicating  myoblasts  were  reseeded at  3.2  x 
104/era  2 on collagen-coated  13-ram-diameter  coverslips and allowed to ad- 
here overnight. Fusion was induced by feeding cultures with DME contain- 
ing 5% HS. 
Representative cultures were labeled at fixed time points (0-56 h) with 
10 #M bromodeoxyuridine (BrdU) (Sigma Chemical Co., Poole,  UK) for 
4 h, fixed in methanol at -20°C for I0 min followed by fixation with 0.2% 
paraformaldehyde for 1 rain.  Finally cultures were treated with 0.07 M 
NaOH for 7-10 rain. BrdU was visualized with a BrdU antibody (Dako 
Corp., Carpinteria, CA) and detected by a Texas red-conjugated secondary 
antibody.  Total nuclei counts in the cultures were assessed after Hoechst 
33258 staining. 
Analysis of  NCAM cis Interactions in the 
Myoblast Membrane 
C2 myoblasts expressing transfected human NCAM were initially reacted 
with ERIC-1 mAb for 90 min at 37"C followed by a fluorescein-conjugated 
anti-mouse Ig secondary antibody for 90 min at 37°C. Cells were then fixed 
for 15 rain with 4% paraformaldehyde and the position of the endogenous 
mouse NCAM visualized using the mAb 1-I28 and a rhodamine labeled rat 
antibody.  The position and amount of clustering of the human and mouse 
NCAM was determined by indirect immunofluorescence  analysis. 
Results 
Expression and Characterization of  Human NCAM in 
1}ansfected C2 Cells 
We have shown previously that transfecfion of mouse C2 
myoblasts with a  eDNA encoding a  125-kD GPI-linked hu- 
man  NCAM  protein  resulted  in  the  expression  of  im- 
munoreactive NCAM at the cell surface. In the present study 
a panel of C2 myoblasts expressing additional NCAM iso- 
forms has been generated. These were two transmembrane 
isoforms of 180 and 140 kD and a GPI-anchored form of 120 
kD. Indirect immunofluorescence staining has been used to 
show coexpression of each of these human isoforms with the 
endogenous mouse NCAM  pool. We have found that for each 
of the  isoforms  analyzed  (180-,  140-,  125-,  and  120-kD 
NCAMs) there was coexpression of the endogenous mouse 
NCAM with the transgene on both myoblasts and myotubes. 
Fig. 1 shows an example of  cells expressing a 140-kD NCAM 
isoform. In each case the distribution of the transgene ap- 
peared random on the cell surface. Western blot analysis of 
the transfected cells was carried out to determine the relative 
molecular mass of the transfected NCAM. Fig. 2 shows that 
Figure L  Coexpression of mouse and human NCAM in transfected C2 cells. Cell surface immunostaining of parental C2 myoblasts (a-c) 
and of myoblast (d-f) and myotube (g-0 cultures of a C2 cell line transfected with a gene construct encoding the 140-kD transmembrane 
form of human NCAM after double staining with human NCAM  specific (b, e,  and h) or mouse specific (c, f  and 0.  Bar,  100 #m. 
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sis  of  transfected  human 
NCAM in C2 cells.  C2 cells 
transfected  with  various  hu- 
man  NCAM  isoforms  were 
analyzed  for  human  NCAM 
using a species  specific anti- 
body.  Samples  were  treated 
with neuraminidase to remove 
sialic acid sidechains. Lane 1, 
180-kD NCAM  transfectant; 
lane 2,  140-kD NCAM trans- 
fectant;  lane  3,  125-kD 
NCAM transfectant; lane 4, 120-kD NCAM transfectant. The mo- 
lecular weight of the reactive bands were calculated from the mo- 
lecular weights of proteins  of known Mr. 
protein bands of 180,  140,  125, and 120 kD could be found 
specifically in cultures  of cells expressing the appropriate 
NCAM isoform. We have shown previously that overexpres- 
sion of human NCAM in C2 cells did not alter the expression 
of the endogenous NCAM pool (Dickson et al.,  1990).  A 
similar  result  was  found  in  the  present  study  (data  not 
shown). 
The level of human NCAM at the cell surface was cal- 
culated  by  binding  of a  ~25I-labeled Fab  fragment of the 
ERIC-1 mAb. Eight different cell lines which by indirect im- 
munofluorescence staining appeared qualitatively to express 
different  levels  of NCAM  were  screened  for  12SI-ERIC-1 
Fab binding.  The highest expressing cell line (C2-Bll) ex- 
pressed 9.6  x  105 human NCAM  sites per cell while the 
lowest expressed 2.5  ×  los sites per cell with intermediate 
values found for the other cell lines. 
The Transmembrane 140-kD NCAM lsoform 
Promotes Myoblast Fusion to a Greater Extent than 
the GPI-linked 125-kD Isoform 
We have shown previously (Dickson et al.,  1990) that trans- 
fection of mouse C2 cells with a cDNA encoding a  125-kD 
GPI-anchored NCAM isoform enhanced myoblast fusion. To 
determine whether the naturally occurring myoblast NCAM 
isoform of 140 kD affected myoblast fusion in the same or 
a  different fashion,  a  comparison of fusion parameters in 
transfected C2 cell lines expressing 125  or 140 kD human 
NCAM isoforms was carded out. The 125-kD NCAM syn- 
thesizing cell line expressed 2.5  x  los sites per cell while 
the 140-kD cell line expressed 2.0  x  l0  s sites per cell. Fig. 
3 shows the time course of fusion over a 4-d period as in- 
dexed by measuring CPK levels for C2 cells and the 125- and 
140-kD transfectants.  C2 cells expressing  125-kD NCAM 
fuse more rapidly and to a slightly greater extent as indexed 
by CPK measurements than wild type C2 cells. The 140-kD 
NCAM expressing cell line was significantly faster in its rate 
of fusion and differences could be detected as early as 2 d 
after plating. These differences increased in magnitude up to 
the day 4  time point.  At that point the  140-kD expressing 
clone had a  CPK value 254% higher than that of C2 cells. 
Similar results were found when an alternative measurement 
namely the percent nuclei in myotubes were made (Fig. 3 B). 
Here the 125-kD expressing clone appeared to fuse faster but 
not to a greater end point than C2 cells, while the  140-kD 
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Figure 3. Effect of 140- and  125-kD transfeeted NCAM isoforms 
on C2 cell fusion.  Parental  and transfected C2 cells were placed 
in culture for various periods of time (1--4 d) before analysis for 
muscle differentation as assessed by the level of CPK in the cell cul- 
tures (.4). The graphs shows the result for C2 cells (A),  125-kD 
NCAM expressing C2 cells  (a,), and  140-kD NCAM expressing 
cells (o). Values are means  +  sere (n  =  3) for independent cul- 
tures.  (B) The same ceils except an alternative measurement (the 
percent nuclei in myotubes) is used.  Here cultures were analyzed 
over a 5-d time period.  Samples were C2 ceils (A),  125-kD ex- 
pressing NCAM transfectants (m), and 140-kD NCAM expressing 
transfectants (e). Values are means  +  sere (n  =  3). 
clone was dramatically faster and almost doubled the nuclei 
in myotubes compared with C2 cells. 
To determine whether the enhanced rate of fusion found 
in the 140- and 125-kD transfectants was related to the level 
of human NCAM in these cell lines a larger number of clones 
synthesizing  different  levels  of human  NCAM  were  ana- 
lyzed. Fig. 4 shows that a series of 140-kD NCAM express- 
ing transfectants analyzed 3 d after plating, all expressed lev- 
els of CPK significantly above C2 cells with a  range from 
150 to 290% and a clear relationship between levels of hu- 
man NCAM and the CPK level was found.  In contrast to 
the 140-kD NCAM transfectants, the  125-kD lines are sig- 
nificantly  less  active on  a  sites per cell basis.  All  of the 
125-kD lines fuse to a greater extent than the C2 ceils (from 
150 to 230%) and there is a relationship between level and 
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Figure 4. Comparison of the effects of expression of different levels 
of 140-kD human NCAM and  125-kD human NCAM on C2 cell 
fusion. C2 cell lines expressing different levels of 140-kD human 
NCAM  (e)  or  125-kD human NCAM  ('9 as assessed  by tzsI- 
labeled  anti-NCAM  Fab binding  were analyzed  for their fusion 
competence in terms of CPK levels and compared to C2 cells (A) 
at a set 3-d time point. Each value is the mean ±  sem from three 
determinations. 
response. However on a comparable sites per cell basis the 
125-kD construct  clearly has less efficacy than  the trans- 
membrane 140-kD construct. 
The 140-kD NCAM Expressing Cell Lines Become 
Postmitotic before C2 Cells 
One of the steps before myoblast fusion is withdrawal from 
the cell cycle and the appearance of postmitotic cells. BrdU 
incorporation can be used as a sensitive index of the prolifer- 
ative capacity of cell populations.  We therefore wished to 
compare the proliferative behavior of NCAM transfected and 
C2 cells to determine whether this might show an alteration 
in parameters earlier than cell fusion. Fig.  5 shows the ki- 
netics of cell cycle withdrawal in C2 cells, and in a transfec- 
tant expressing the transmembrane 140-kD NCAM isoform. 
Over the 56-h period of analysis C2 cells progressively leave 
the cell cycle and become postmitotic. This is in line with 
the culture kinetics where myotubes are starting to appear 
by day 2 in the C2 cultures. (Fig. 3 b). The same graph (Fig. 
3 B) shows that the 140-kD NCAM expressing transfectants 
have >40%  of nuclei in myotubes at day 2. Thus the rapid 
rise in fusion is accompanied by a dramatic decrease in the 
mitotic index (Fig.  5) such that there is a major difference 
between the C2 cells and the  140-kD expressing line.  The 
140-kD expressing C2 cell line contains virtually no mitotic 
cells after 36 h of culture while the C2 cells have 35 % mi- 
totic cells at this time point. We also found that the 180-kD 
NCAM transfectants are similar to the 140-14) transfectants 
(data not shown). However both the 120- and 125-kD GPI- 
linked NCAM isoforms were identical to the C2 profile and 
Fig.  5  shows the result for the  125-kD transfectant,  It re- 
mains  to  be determined  whether  these  results  indicate  a 
difference in mechanism of action or sensitivity of assay sys- 
tems under study. 
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Figure 5. Comparison of the number of postmitotic cells with time 
in cultures of C2 cells versus transfected C2 cells expressing 140- 
kD human  NCAM.  C2  cells  (A),  125- (=) and  140-kD human 
NCAM transfected C2 cells (e) were cultured on slides and at set 
periods of time (0-56 h) were pulsed with BrdU for 4 h.  At that 
point samples were fixed and reacted with anti BrdU. The percent- 
age of BrdU  positive nuclei  is plotted  against time.  Each value 
represents the mean ±  sem of three determinations. 
The Transmembrane 180-kD NCAM lsoform 
Enhances Myoblast Fusion in a Similar Manner to 
the 140-kD Transmembrane Isoform 
The largest NCAM isoform of 180 kD is identical to the 140- 
kD isoform except that it has a longer cytoplasmic domain. 
It is expressed transiently in myotomes around day 9 in the 
mouse embryo both by in situ hybridization (Lyons et al., 
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Figure  6. The transmembran¢ 180-kD NCAM ~.oform enhances fu- 
sion to the same degree as the 140-kD isoforn£ Comparison of fu- 
sion in two pairs of NCAM transfectants that synthesize roughly 
equal amounts of human NCAM. Cells were placed in culture and 
analyzed for CPK at day 3. a shows the result for 140-10) expressing 
NCAM (C2C5 cells, 2.0  x  105 sites per cell of NCAM;  I) and 
180-kD  expressing  (C2R5  cells;  1.9  x  105  sites  per  cell  of 
NCAM; ~), Each value is the mean sem pooled for three deter- 
minations, b shows the result for the second pair of transfectants. 
These were the  140-kD expressing cells (C2C6 cells, 2.9  x  105 
sites per cell of NCAM;  m) and  180-kD expressing transfectant 
(C2R2 cells,  3.0  x  105 sites per cell of NCAM,  ~). Each value 
is the mean  +  sem pooled from three determinations. 
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~'gure 7. Human NCAM antibodies specifically block the enhance- 
ment of fusion induced by transfected NCAM. C2 cells and a line 
of 140- and 180-kD transfectants were cultured in the presence and 
absence of the blocking ERIC-1 mAb and the non blocking 5.1 Hll 
mAb that both react specifically with human NACM. Samples were 
analyzed for CPK activity after 3 d in culture either in control cul- 
tures  (I). Nonblocking  5.1  Hll  mAb ([]) and blocking  ERIC-1 
mAb (ra). Values are expressed as the mean ±  sem (n = 3). 100% 
values relate to 58.98 U CPK. 
1992)  and  immunocytochemistry  (Thiery  et  al.,  1982). 
Small levels have also been transiently found in some muscle 
ceils in culture (Tassin et al.,  1991).  It was therefore of in- 
terest to determine whether this isoform was as active as the 
140-kD isofonn. Fig. 6 shows that in two independent 180- 
kD NCAM expressing cell lines tested 3 d after plating there 
was a roughly similar enhancement of fusion. There was no 
difference statistically between the  180-kD cell line C2R5 
and the 140-kD expressing C2C5 line or between the C2C6 
and C2R2 cell lines where both pairs synthesized roughly the 
same amount of transfected NCAM. Thus both a large and 
a small cytoplasmic domain seems to be capable of mediat- 
ing the positive effects on myoblast fusion. 
Antibodies to Human NCAM Reverse the 140- and 
180-kD NCAM-mediated Enhancement of  Fusion 
To show that the enhanced fusion seen in the 140- and 180- 
kD NCAM transfectants was due to the expression of the 
transgene,  a  blocking  antibody  approach  using  species- 
specific antibodies was used. We have shown previously that 
Fab fragments of the human specific NCAM blocking mAb 
called ERIC 1 but not other NCAM antibodies would block 
the  enhanced  fusion  due  to  transfected  125-kD  NCAM 
(Dickson et al.,  1990).  Fig. 7 extends this approach to the 
140- and  180-kD isoforms. The addition of 300/zg/ml  of 
ERIC-1 Fab led to a significant reversal of the enhanced fu- 
sion found to be due to the 180- and 140-kD isoforms while 
non blocking NCAM antibodies had no effect as found previ- 
ously. In addition to the biochemical marker of differentia- 
tion (CPK) Shown in Fig.  7  similar effects were found for 
morphological differentiation. ERIC-1 antibody at 300 ttg/rnl 
resulted in a 35 % decrease in the percent nuclei in myotubes 
in a  140-kD NCAM expressing cell line at day 3 of fusion. 
The positive effects of NCAM expression are specific and 
seem to be directly related to greater expression of NCAM 
rather than some general perturbation of the plasma mem- 
brane. 
The GPI-linked NCAM Isoform of 120 kD Has No 
Effect on C2 Cell Fusion 
The GPI-anchored isoform of NCAM found on skeletal mus- 
cle myotubes is of 125 kD with no evidence of the 120-kD 
isoform which  is  found on other  cells such as gllal cells 
(Walsh  and  Doherty,  1991).  The only difference between 
these isoforms is the presence of the MSD1 region which is 
a sequence of 37 amino acids between the type HI fibronectin 
repeats  in  the  extracellular  domain  (Walsh  and  Doberty, 
1991).  To determine whether the MSD1 region is important 
in the process of fusion the 120-kD isoform which is lacking 
in this region only has been analyzed. Three cell lines ex- 
pressing 3.53  x  105, 4.18  ×  105, 4.86  x  105, sites per cell 
of human NCAM were screened for their effects on fusion 
and  compared with  the  positively acting  125-kD  NCAM 
clone which  expresses 4.3  ×  105  sites per cell of human 
NCAM. In all three cell lines expressing the 120-kD NCAM 
isoform there was no enhancement of fusion but a small inhi- 
bition which was not statistically different from C2 cell fu- 
sion (Fig. 8). Thus the 120-kD isoform neither enhances or 
inhibits fusion while the 125-kD control clone significantly 
enhances fusion. Thus it seems likely that the MSD-1 region 
is a positive modulator of myoblast fusion. 
Co-clustering of Transfected NCAM and the 
Endogenous NCAM Pool in C2 Myoblasts 
The overexpression of transmembrane and the 125-kD GPI 
NCAM isoform but not the 120-kD GPI isoform in C2 cells 
leads to enhanced fusion. One mechanistic possibility is that 
there are cis interactions occurring in the cell membrane, in 
addition to the obvious trans interactions between NCAM 
isoforms that mediate these effects. The availability of spe- 
cies specific NCAM antibodies allows for the study of possi- 
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Figure 8. Transfection of C2 cells with 120-kD NCAM has no effect 
on fusion. Three C2 cells lines cells synthesizing ditferent amounts 
of human  NCAM ([b]3.53  ×  105 sites per cell;  [c] 4.18  ×  105 
sites per cell; and [d] 4.86  ×  105 sites per cell) were compared 
with a 125-kD NCAM expressing cell line ([a] 4.30  x  105 sites 
per cell). Cells were placed in culture and analyzed at day 3 when 
CPK levels were  measured  and  compared  to control  C2  cells. 
Values are means  ±  sere (n  =  3). 
/ 
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nous  NCAM  in  the  same  cells.  The  transfected  human 
NCAM can be clustered in the membrane of C2 myoblasts 
by a double antibody binding method. The NCAM reactive 
ERIC-1  rnAb  was  bound  to  cells  followed  by  rabbit 
anti-mouse Ig. This led to the formation of micro-clusters 
in the cell membrane due to crosslinking (Fig.  9).  It was 
found that the majority (>90%) of the human NCAM could 
be  clustered by  this  method  and  was  a  reproduceable 
phenomena being  found in six independent experiments. The 
phenomena was observed in the four cell lines that synthe- 
sized 180-,  140-,  125-, and 120-kD NCAM (Fig. 9). An as- 
sessment was also made as to whether there was any mouse 
NCAM in the human NCAM clusters. Fig. 9 shows that in 
human  NCAM  clusters  from the  180-,  140-,  and  125-kD 
transfectants there was  a  co-clustering of mouse NCAM. 
The 120-kD human NCAM expressing cell line was different 
because it was unable to co-cluster the endogenous NCAM 
pool. However a mouse NCAM antibody was able to cluster 
this pool showing that transfection with the 120-kD isoform 
did  not  irreversibly  alter  the  ability  of the  endogenous 
NCAM pool to cluster. Thus there appears to be cis interac- 
tions between human and mouse NCAM occurring in the 
plane of the plasma  membrane.  The fact that the  125-kD 
GPI-linked NCAM can co-cluster the endogenous NCAM 
pool but the 120-kD expressing transfectant cannot suggests 
that this phenomenon can be determined by sequence in the 
extracellular part of the NCAM protein. 
Discussion 
At the cell surface CAMs have been shown to be crucial com- 
ponents  in  the  process  of myoblast  fusion  to  form mul- 
Figure 9.  Co-clustering of the  endogenous mouse NCAM with 
transfected human NCAM in the C2 cell membrane. C2 cells (a and 
b) or transfected C2 cells synthesizing 125- (c and d),  140- (e and 
jr); 180- (g and h), and 120- (i and  j) kD human NCAM were reacted 
first with human NCAM specific ER/C-1 mAb followed  by labeled 
anti-mouse Ig. Samples were then fixed  with paraformaldehyde  and 
the pattern of expression of the endogenous mouse NCAM pool 
studied. (a-t) shows the reactivity found for human NCAM stained 
with fluorescein while (b-j) shows the endogenous NCAM pool 
stained with rhodamine. As there is no human NCAM reactivity 
in the C2 cells (a) there is no reactivity in this panel. Bar, 100/zm. 
tinucleate myotubes.  CAM  families are likely involved at 
both the initial recognition events that may lead to transmis- 
sion of specific signals and also the strong stable adhesive 
events that may be required before membrane union. It also 
seems likely that CAMs do not operate in isolation and that 
there  are  functional interactions between CAMs.  For in- 
stance in the myoblast membrane there are close associations 
between NCAM and N-cadherin that can be identified by im- 
munoc~ytochemical  means (Knudsen et al.,  1990; Mege et 
al.,  1992). 
A detailed picture of NCAM expression in skeletal muscle 
has been produced.  Myoblasts express predominantly the 
transmembrane  140-kD isoform while myotubes express a 
GPI-linked 125-kD form (Covanlt et al., 1986; Moore et al., 
1987). During the myoblast to myotube transition the tran- 
scriptional  rate  of the  gene  also  increases  (Roubin  and 
Goridis, 1992). These studies have tended to suggest a role 
for NCAM in myoblast fusion although how or where it is 
acting has not been clear. We have previously analyzed the 
function of the 125-kD GPI-linked NCAM isoform in myo- 
blast fusion by gene transfer (Dickson et al., 1990). Consti- 
tutive overexpression of this isoform caused an enhancement 
in the rate of fusion as assessed by both morphological and 
biochemical parameters. In the present study we have ana- 
lyzed the effect of introducing additional forms of NCAM 
into the myoblast membrane. These include two transmem- 
brane forms of 140 and 180 kD and a GPI-linked form of 120 
kD.  While the 140-kD isoform is the main NCAM of myo- 
blasts (Moore et al.,  1987) and the  180-kD isoform is ex- 
pressed transiently in somites (Lyons et al.,  1992) the 120- 
kD isoform is never found in skeletal muscle but is highly 
expressed on cells such as glia (Walsh  and Doberty, 1991). 
A comparison of the 120 versus the 125-kD isoforms does 
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in the extraceliular domain of NCAM is involved in the fu- 
sion process. In the present study we provide evidence that 
the transmembrane NCAM isoforms of 140 and 180 kD en- 
hance muscle fusion compared to the 125-kD isoform. In- 
terestingly the 120-kD isoform when expressed in C2 cells 
is neutral and does not alter fusion although there was some 
evidence of a slight inhibition which in the present model 
was not significant. The effect of overexpressing the 140-kD 
isoform was dramatic. There was a doubling of the percent- 
age of nuclei in myotubes and about a threefold increase in 
the level of creatine kinase in the culture after 4-5 d. These 
effects are more dramatic than our previous study with the 
125-kD isoform (Dickson et al., 1990). In both cases the rate 
of fusion was greater than in C2 cells. That the differences 
between the 140- and 125-kD isoforms were not just due to 
different levels of effpression of the transgene was shown by 
comparing the fusion competence of a panel of 140- and 125- 
kD expressing cell lines. There was a clear relationship be- 
tween the fusion competence of cell lines and the level of 140 
or 125 kD NCAM expressed. Howeverl in all cases the 140- 
kD NCAM was always more active on the basis of specific 
levels. The positive effects on fusion were also blocked by 
species-specific antibodies that reacted With the transfected 
human NCAM. It therefore appears likely that the effects on 
fusion are due to expression of the transfected NCAM. One 
other index of the culture dynamics in the C2 and transfected 
cell lines was the analysis of the mitotic index via BrdU in- 
corporation. Here there was a marked difference  between the 
behavior of the 140-kD NCAM transfectants and C2 cells 
with the 140-kD expressing cells were becoming postmitotic 
•24  h before the C2 ceils. It also appeared that the 125- and 
120-kD NCAM transfectants behaved in the same manner as 
the C2 cells. It is not clear at present whether this is due to 
some  fundamentally different mechanism operating or to 
differences in the sensitivity of the different assay systems. 
The 180-kD NCAM protein is an alternatively spliced form 
of the  140-kD isoform with a  larger intracellular domain. 
The 120-kD isoform is also similar to the 125-kD isoform 
except that the former does not use the MSD exons between 
exon 12 and 13 encoding the extracellular domain. The 180- 
kD transfectants behave in a very similar manner to the 140- 
kD transfectants. In contrast, the 120-kD transfectants be- 
have very differently. Overexpression of the 120-kD isoform 
in the C2 membrane does not alter any of the parameters as- 
sociated with fusion in a significant manner. This is in con- 
trast to PC12 cells where the expression of the same eDNA 
construct led to an inhibition of NCAM mediated signaling 
events and acts like a dominant negative mutant (J. Saffell, 
unpublished  observations).  These results  suggest  that  al- 
though the 120 kD NCAM has the capacity to become in- 
volved in homophilic interactions in C2 cells it may not alter 
the  ability  of  the  endogenous  pool  to  be  involved  in 
homophilic interactions. There may also be other compensa- 
tory mechanisms involving other CAMs that mask the effect 
of some loss of NCAM function in these cells. 
The  enhanced  morphological  and  biochemical  events 
associated  with  NCAM-mediated  fusion may  indicate an 
inherent plasticity associated with NCAM-mediated inter- 
actions. Transfection of the calcium-dependent CAM N-cad- 
herin into C2 cells leads to blockade of fusion at a number 
of different expression levels (Peck, D., and E  S. Walsh, un- 
published observations). The exact mechanism of NCAM 
mediated fusion enhancement is not clear at present. In the 
growth  cone  of  neurons  we  have  shown  that  NCAM- 
mediated homophilic binding results in activation of  a signal- 
ing pathway which ultimately leads to calcium influx via 
L- and N-type calcium channels (Doherty and Walsh, 1992; 
Doherty et al.,  1992b).  Interestingly only transmembrane 
NCAM isoforms appear to be able to participate in the pro- 
cess suggesting that either the transmembrane regions or in- 
tracellular domains are important.  The observation that a 
number of CAMs appear to be able to activate this pathway 
has led to the suggestion that they may be operating through 
some form of  "adaptor  ~ molecule (Doherty and Walsh, 1992; 
Doherty et al., 1992b; Williams et al., 1992). The clustering 
of NCAM in the cell membrane via cis interactions may be 
controlled at the level of the membrane anchoring mecha- 
nism. Bloch 0992) has also recently shown that NCAM can 
be clustered in the membrane of C2 myoblasts, Additionally 
we have found (Walsh, Fo S., and K. Jacobson, unpublished 
observations) that GPI-linked NCAM is more mobile in the 
plane of the cell membrane of neuronal PC12  cells than 
transmembrane NCAM isoforms. Thus GPI-anchored NCAM 
in these cells may be able to interact with NCAM in the 
monolayer in co-culture experiments but because of mobility 
considerations is unable to form interactions that will allow 
co-clustering of adaptor molecules. In contrast the 140- and 
180-kD transmembrane isoforms move much slower in PC12 
cells and allow stable associations to occur. A similar situa- 
tion may occur during myogenesis where the NCAM iso- 
forms on both bilayers that are interacting are identical. We 
have found that the exogenous transmembrane NCAM iso- 
forms and the 125-kD GPI isoforms will co-cluster with the 
endogenous  NCAM  pool.  However the  120-kD  isoform 
never co-clusters. This data is paralleled by mobility mea- 
surements where the transmembrane NCAM isoforms move 
slowest in the C2 membrane, followed by the 125-kD GPI- 
linked  isoform containing the  MSD  sequences while the 
120-kD GPI-linked isoform is fastest (unpublished obser- 
vations).  Whether there are any transmembrane signaling 
events associated with NcAM-mediated interactions in fu- 
sion is not clear. What is clear from the present study is 
that the transmembrane and/or the cytoplasmic domains of 
NCAM are important for the enhancement of fusion as is the 
MSD region and it is possible that positive effects can be in- 
terpreted in terms of NCAM mobility in the plasma mem- 
brane. This study is the first indication as to the function of 
the MSD region on skeletal muscle NCAM.  The region is 
rich in the amino acids serine, threonine, and proline and is 
known to be a  site of O-linked carbohydrate attachment 
CqCalsh et al., 1989). It is possible that the O-linked carbohy- 
drate alters the mobility of NCAM via specific cis interac- 
tions but it is also possible that the protein core is also in- 
volved. Some evidence has been presented that NCAM may 
interact with the L1 CAM and this interaction involves car- 
bohydrate residues on the L1 glycoprotein (Kadmon et al., 
1990). 
One of the unusual features of the NCAM gene has been 
the relatively large number of isoforms that can be produced 
from alternative splicing of the single copy NCAM  gene. 
Skeletal muscle is characterized by the orderly progression 
of isoform expression associated with alternative splicing. 
However a  role for the different NCAM isoforms has not 
been apparent.  The present study using  gene transfer of 
different NCAM isoforms has identified roles for the major 
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of exons which are specific to skeletal muscle when used as 
a block (Dickson et al.,  1986;  Harnshere  et al.,  1992;  Pan 
et al.,  1992;  Thompson et al.,  1988) and which is a site of 
O-linked carbohydrate attachment, have a role in the process 
of muscle fusion. The strategies presented here however pro- 
vide one way forward to dissecting the role of specific cell 
surface components in this process. 
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